Andrew Pennell

Andrew Pennell has a background in chemistry and pharmaceutical development. With experience in companies like Arcus Biosciences, ChemoCentryx, Genesoft Inc., and Glaxo Wellcome, Andrew has held various leadership roles in medicinal chemistry and drug development. Andrew's expertise includes working on cancer immunotherapies, autoimmune diseases, inflammatory disorders, and infectious diseases. Andrew also has a PhD in Organic Chemistry from Imperial College London.